High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Rebekka Wegmann et al.|Nature Medicine|2024Cited by 68
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivšek, Berend Snijder, Nadja Dietliker et al.|Nature Cancer|2023Cited by 42
Molecular and functional landscape of malignant serous effusions for precision oncologyRebekka Wegmann, Berend Snijder, Fabian Arnold et al.|Nature Communications|2024Cited by 11